A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Gilead Sciences
Allogene Therapeutics
Gilead Sciences
Celgene
Affimed GmbH
University of Illinois at Chicago
CARGO Therapeutics
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Keimyung University Dongsan Medical Center
Lymphoma Study Association
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Chicago
Samsung Medical Center
University of Michigan Rogel Cancer Center
Gruppo Italiano Studio Linfomi